
We describe zzso for the first time our medicinal zzso zzso design of zzso zzso drugs and zzso zzso as newly emerging drug zzso A new area of zzso drugs and treatments has recently focused on zzso cells of the tumor zzso involving accessory zzso This tumor hypoxic environment is now considered as a major factor that influences not only the response to zzso therapies but also the potential for zzso progression and zzso We review our medicinal zzso zzso design of zzso drugs, zzso hypoxic cell zzso zzso hypoxic cell zzso and zzso zzso delivery agents, in which we design drug candidates based on their electronic structures obtained by molecular zzso calculations, not based solely on zzso zzso These drugs include an zzso hypoxic cell zzso zzso a zzso hypoxic cell zzso zzso new zzso zzso zzso zzso zzso and a zzso zzso agent, zzso zzso zzso zzso zzso zzso hybrid drug zzso We then discuss the concept of zzso zzso as a new drug class having broad potential in many zzso 

